Your browser doesn't support javascript.
loading
The Alzheimer's disease drug development landscape.
van Bokhoven, Pieter; de Wilde, Arno; Vermunt, Lisa; Leferink, Prisca S; Heetveld, Sasja; Cummings, Jeffrey; Scheltens, Philip; Vijverberg, Everard G B.
Afiliación
  • van Bokhoven P; Industry Alliance Office, Amsterdam Neuroscience, Amsterdam University Medical Centers, Amsterdam, The Netherlands. p.vanbokhoven@amsterdamumc.nl.
  • de Wilde A; Life Science Partners (LSP), Amsterdam, The Netherlands.
  • Vermunt L; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Leferink PS; Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Heetveld S; Industry Alliance Office, Amsterdam Neuroscience, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Cummings J; Industry Alliance Office, Amsterdam Neuroscience, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Scheltens P; Chambers-Grundy Center for Transformative Neuroscience, Department of Brain Health, School of Integrated Health Sciences, University of Nevada Las Vegas (UNLV), Las Vegas, NV, USA.
  • Vijverberg EGB; Life Science Partners (LSP), Amsterdam, The Netherlands.
Alzheimers Res Ther ; 13(1): 186, 2021 11 11.
Article en En | MEDLINE | ID: mdl-34763720
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Neurodegenerativas / Enfermedad de Alzheimer Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Alzheimers Res Ther Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Neurodegenerativas / Enfermedad de Alzheimer Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Alzheimers Res Ther Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos